PLA2G7 and stroke disorder: In 2007, the American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) published guidelines for the management of dyslipidemia and prevention of cardiovascular disease, with the recommendation that patients at risk of cardiovascular or stroke be evaluated for serum Lp-PLA2 activity and mass [57].